Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CardiolRx in Recurrent Pericarditis
NCT06708299Phase 3Recruiting
- Sponsor
- Cardiol Therapeutics Inc.
- Start
- Apr 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of cannabidiol in recurrent pericarditis, sponsored by Cardiol Therapeutics Inc.. Started Apr 2025; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
recurrent pericarditis
Beyond the preview
Go deeper on NCT06708299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06708299.